South Korea to start talks on COVID-19 drug remdesivir purchases

South Korea said it will begin talks with Gilead Sciences to purchase stocks of remdesivir, one of the first drugs shown to be effective against COVID-19, after the company agreed to allocate nearly all of its supply to the U.S. over the next three months.

Subscribe: http://smarturl.it/reuterssubscribe

Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.

Get the latest news on: http://smarturl.it/reuterssubscribe
Follow Reuters on Facebook: http://smarturl.it/reuterssubscribe
Follow Reuters on Twitter: http://smarturl.it/reuterssubscribe
Follow Reuters on Instagram: http://smarturl.it/reuterssubscribe